These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12867576)

  • 21. [The role of osteoclasts on the bone destruction of rheumatoid arthritis and the mechanism of its regulation].
    Wang L; Wang WJ
    Sheng Li Ke Xue Jin Zhan; 2004 Jul; 35(3):269-72. PubMed ID: 15469104
    [No Abstract]   [Full Text] [Related]  

  • 22. [Regulation of osteoclast activity: a new approach in the therapy of bone diseases].
    Vanhara P; Smarda J
    Cas Lek Cesk; 2006; 145(8):606-10. PubMed ID: 16995415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
    Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
    Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fc-gamma receptors and S100A8/A9 cause bone erosion during rheumatoid arthritis. Do they act as partners in crime?
    Di Ceglie I; Kruisbergen NNL; van den Bosch MHJ; van Lent PLEM
    Rheumatology (Oxford); 2019 Aug; 58(8):1331-1343. PubMed ID: 31180451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dynamic interplay between osteoclasts and the immune system.
    Nakashima T; Takayanagi H
    Arch Biochem Biophys; 2008 May; 473(2):166-71. PubMed ID: 18410741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-7 in rheumatoid arthritis.
    Churchman SM; Ponchel F
    Rheumatology (Oxford); 2008 Jun; 47(6):753-9. PubMed ID: 18356170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arming the osteoclast.
    Baron R
    Nat Med; 2004 May; 10(5):458-60. PubMed ID: 15122243
    [No Abstract]   [Full Text] [Related]  

  • 28. [Osteoclast differentiation and activation].
    Takayanagi H
    Clin Calcium; 2007 Apr; 17(4):484-92. PubMed ID: 17404476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mediators of inflammation and bone remodeling in rheumatic disease.
    Shaw AT; Gravallese EM
    Semin Cell Dev Biol; 2016 Jan; 49():2-10. PubMed ID: 26481971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.
    Sato K; Suematsu A; Okamoto K; Yamaguchi A; Morishita Y; Kadono Y; Tanaka S; Kodama T; Akira S; Iwakura Y; Cua DJ; Takayanagi H
    J Exp Med; 2006 Nov; 203(12):2673-82. PubMed ID: 17088434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of osteoclasts in bone destruction in rheumatoid arthritis].
    Suzuki Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Jun; 24(3):87-97. PubMed ID: 16578961
    [No Abstract]   [Full Text] [Related]  

  • 32. [Osteoimmunology-overview].
    Ono T; Takayanagi H
    Clin Calcium; 2016 May; 26(5):661-9. PubMed ID: 27117610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
    Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
    J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.
    Romas E
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1065-79. PubMed ID: 16301197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular determinants in osteoclast differentiation and osteoimmunology].
    Takayanagi H
    Rinsho Ketsueki; 2009 Jun; 50(6):447-52. PubMed ID: 19571503
    [No Abstract]   [Full Text] [Related]  

  • 38. Rheumatic diseases: the effects of inflammation on bone.
    Walsh NC; Crotti TN; Goldring SR; Gravallese EM
    Immunol Rev; 2005 Dec; 208():228-51. PubMed ID: 16313352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment.
    Bugatti S; Caporali R; Manzo A; Vitolo B; Pitzalis C; Montecucco C
    Arthritis Rheum; 2005 Nov; 52(11):3448-59. PubMed ID: 16258900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.
    Miranda-Carús ME; Benito-Miguel M; Balsa A; Cobo-Ibáñez T; Pérez de Ayala C; Pascual-Salcedo D; Martín-Mola E
    Arthritis Rheum; 2006 Apr; 54(4):1151-64. PubMed ID: 16575870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.